You may find more results for this query on our sister sites: GenomeWeb and 360Dx.
The assay underwent clinical validation at three centers in Singapore and 5,248 patients were ultimately screened using the test.
Informaticians from Georgetown and other major cancer centers expect their technology to bring precision oncology services to community hospitals and clinics.
The test relies on a signature that Almac developed for stratifying breast cancer patients, but which, as the researchers showed, can be used in other cancers as well.
Informaticians at Spain's National Cancer Research Centre develop a methodology for evaluating likely drug efficacy based on specific patient genotypes.